Prostatis Group’s Vanguard FTSE Emerging Markets ETF VWO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-17,677
Closed -$774K – 157
2024
Q2
$774K Sell
17,677
-1,802
-9% -$77.6K 0.27% 78
2024
Q1
$814K Buy
+19,479
New +$795K 0.31% 72
2023
Q4
– Sell
-34,371
Closed -$1.35M – 142
2023
Q3
$1.35M Sell
34,371
-50,944
-60% -$2.08M 0.66% 35
2023
Q2
$121K Buy
+85,315
New +$3.44M 0.06% 130
2023
Q1
– Sell
-13,654
Closed -$532K – 115
2022
Q4
$532K Buy
+13,654
New +$521K 0.32% 61
2021
Q1
– Sell
-20,112
Closed -$1.01M – 101
2020
Q4
$1.01M Sell
20,112
-30,651
-60% -$1.44M 0.84% 26
2020
Q3
$2.19M Buy
+50,763
New +$2.21M 2.08% 15

Other funds holding VWO

Prostatis Group's VWO Position: Q3 2024 in Review

Prostatis Group sold out of Vanguard FTSE Emerging Markets ETF (VWO) in Q3 2024, closing a stake of 17,677 shares — an estimated $774K sold.

Prostatis Group first reported a position in VWO in Q3 2020 and held it in 7 quarters. The position peaked at $2.19M in Q3 2020. 2,095 funds tracked by Wall St. Rank hold VWO as of Q3 2024.

  • Prostatis Group reported no remaining Vanguard FTSE Emerging Markets ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 17,677 Vanguard FTSE Emerging Markets ETF shares in Q3 2024, an estimated $774K.
  • Prostatis Group first reported a position in Vanguard FTSE Emerging Markets ETF in Q3 2020 and held it in 7 quarters.
  • Prostatis Group's Vanguard FTSE Emerging Markets ETF position peaked at $2.19M in Q3 2020.
  • 2,095 funds tracked by Wall St. Rank held Vanguard FTSE Emerging Markets ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.